The National Drug and Health Products Agency of Tunisia has introduced a new system allowing citizens and professionals to report any suspect or counterfeit medicines or health products. This move aims to enhance regulatory oversight and protect public health. The agency has made this service available to the general public, targeting all stakeholders, including patients, consumers, and healthcare professionals.
The agency has outlined key indicators that necessitate reporting, such as unusual packaging, unfamiliar product appearance, unexpected effects after product use, and instances of products being sold outside authorized channels or at suspiciously low prices. These indicators will help identify potential health risks and enable swift action to mitigate them.
The agency has categorized reportable cases into two main categories: products that do not meet standards and counterfeit products. The first category includes licensed medicines that fail to meet technical specifications and quality standards. The second category involves counterfeit medicines or products with false or misleading information regarding their identity, chemical composition, or origin.
To facilitate reporting, the National Drug Agency has established three direct channels: an online platform with an electronic form on its official website, an email address for submitting details and documents, and a postal address for depositing formal reports. The agency encourages reporters to provide as much detail as possible about the product in question.
The agency has assured reporters that their identities will be protected and that submitted data will be kept confidential. Reports can be submitted anonymously. By providing detailed information, such as product name, dosage, batch number, expiration date, and purchase circumstances, reporters enable the agency to verify and respond quickly to potential health threats.
The National Drug Agency has emphasized the importance of public and professional vigilance in detecting suspect products. These reports enable the agency's experts to intervene promptly, withdraw non-compliant shipments, and issue necessary warnings to protect public health. The agency's proactive approach underscores its commitment to ensuring the safety and efficacy of health products in Tunisia.
The introduction of this reporting mechanism reflects the agency's dedication to transparency and public safety. By engaging citizens and professionals in the monitoring process, the agency aims to enhance the overall quality of health products and safeguard public health. The agency's efforts are expected to contribute significantly to the country's healthcare sector.
Key points
- The National Drug Agency has established a formal mechanism for reporting suspect or counterfeit health products to enhance regulatory oversight and protect public health.
